BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 35269744)

  • 1. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
    Cinque A; Capasso A; Vago R; Floris M; Lee MW; Minnei R; Trevisani F
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
    Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
    BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network architecture of non-coding RNAs provides insights into the pathogenesis of upper tract urothelial carcinoma.
    Fu T; Lin Y; Lin L; Yang Y; Guo Q; Long Y; He H; Bao Y; Lin T; Chen J; Chen Z; Du L; Liao G; Liao B; Huang J
    Urol Oncol; 2022 Aug; 40(8):383.e11-383.e21. PubMed ID: 35659483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics in upper tract urothelial carcinoma.
    Kammerer-Jacquet SF; Mathieu R; Peyronnet B; Rioux-Leclercq N; Bensalah K
    Curr Opin Urol; 2017 Jan; 27(1):35-40. PubMed ID: 27584028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    Soria F; Shariat SF; Lerner SP; Fritsche HM; Rink M; Kassouf W; Spiess PE; Lotan Y; Ye D; Fernández MI; Kikuchi E; Chade DC; Babjuk M; Grollman AP; Thalmann GN
    World J Urol; 2017 Mar; 35(3):379-387. PubMed ID: 27604375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].
    Nison L; Bozzini G; Rouprêt M; Traxer O; Colin P
    Prog Urol; 2014 Nov; 24(15):977-86. PubMed ID: 25199724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
    Gutierrez CM; Alemozaffar M; Osunkoya AO
    Hum Pathol; 2019 Oct; 92():18-24. PubMed ID: 31351154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.
    Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L
    BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular aspects of upper tract urothelial carcinoma.
    Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
    Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma.
    Skala SL; Liu TY; Udager AM; Weizer AZ; Montgomery JS; Palapattu GS; Siddiqui J; Cao X; Fields K; Abugharib AE; Soliman M; Hafez KS; Miller D; Lee CT; Alva A; Chinnaiyan AM; Morgan TM; Spratt DE; Jiang H; Mehra R
    Eur Urol Focus; 2017 Oct; 3(4-5):502-509. PubMed ID: 28753826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker.
    Kobayashi G; Hayashi T; Sentani K; Takemoto K; Sekino Y; Uraoka N; Hanamoto M; Nose H; Teishima J; Arihiro K; Hinata N; Oue N
    Pathol Int; 2022 Dec; 72(12):606-616. PubMed ID: 36169278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.